Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intralesional Ranibizumab on Pterygium Vascularity, Size and Recurrence Rate: a Pilot Study

NCT02342392 is registered in ClinicalTrials.gov with Universiti Sains Malaysia as lead sponsor.

NCT NCT02342392
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02342392 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intralesional Ranibizumab on Pterygium Vascularity, Size and Recurrence Rate: a Pilot Study
Lead sponsor
Universiti Sains Malaysia
Phase
Phase 2/3
Overall status
Completed
Start date
September 30, 2012
Completion date
September 30, 2014
Enrollment
36 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

pterygium